156 related articles for article (PubMed ID: 25756001)
1. In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex.
Hattori Y; Nakamura A; Arai S; Nishigaki M; Ohkura H; Kawano K; Maitani Y; Yonemochi E
Results Pharma Sci; 2014; 4():1-7. PubMed ID: 25756001
[TBL] [Abstract][Full Text] [Related]
2. Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection.
Hattori Y; Yamasaku H; Maitani Y
J Drug Target; 2013 Aug; 21(7):639-47. PubMed ID: 23594095
[TBL] [Abstract][Full Text] [Related]
3. Sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA could effectively deliver siRNA to the liver.
Hattori Y; Arai S; Okamoto R; Hamada M; Kawano K; Yonemochi E
Int J Pharm; 2014 Dec; 476(1-2):289-98. PubMed ID: 25290812
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
[TBL] [Abstract][Full Text] [Related]
5. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
7. Poly(γ-glutamic acid)-coated lipoplexes loaded with Doxorubicin for enhancing the antitumor activity against liver tumors.
Qi N; Tang B; Liu G; Liang X
Nanoscale Res Lett; 2017 Dec; 12(1):361. PubMed ID: 28532126
[TBL] [Abstract][Full Text] [Related]
8. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
[TBL] [Abstract][Full Text] [Related]
9. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor.
Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y
J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749
[TBL] [Abstract][Full Text] [Related]
10. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
[TBL] [Abstract][Full Text] [Related]
11. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system.
Sakurai F; Nishioka T; Yamashita F; Takakura Y; Hashida M
Eur J Pharm Biopharm; 2001 Sep; 52(2):165-72. PubMed ID: 11522482
[TBL] [Abstract][Full Text] [Related]
12. Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy.
Kurosaki T; Kitahara T; Kawakami S; Higuchi Y; Yamaguchi A; Nakagawa H; Kodama Y; Hamamoto T; Hashida M; Sasaki H
J Control Release; 2010 Mar; 142(3):404-10. PubMed ID: 19931327
[TBL] [Abstract][Full Text] [Related]
13. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
Hattori Y; Saito H; Oku T; Ozaki KI
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
[TBL] [Abstract][Full Text] [Related]
14. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
Lee J; Ahn HJ
Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
[TBL] [Abstract][Full Text] [Related]
15. Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method.
Tang M; Sagawa A; Inoue N; Torii S; Tomita K; Hattori Y
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111627
[TBL] [Abstract][Full Text] [Related]
16. Reduced in vitro and in vivo toxicity of siRNA-lipoplexes with addition of polyglutamate.
Schlegel A; Bigey P; Dhotel H; Scherman D; Escriou V
J Control Release; 2013 Jan; 165(1):1-8. PubMed ID: 23123257
[TBL] [Abstract][Full Text] [Related]
17. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration.
Barron LG; Gagné L; Szoka FC
Hum Gene Ther; 1999 Jul; 10(10):1683-94. PubMed ID: 10428213
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate capsule system for efficient and secure gene delivery.
Kurosaki T; Kitahara T; Fumoto S; Nishida K; Yamamoto K; Nakagawa H; Kodama Y; Higuchi N; Nakamura T; Sasaki H
J Pharm Pharm Sci; 2010; 13(3):351-61. PubMed ID: 21092708
[TBL] [Abstract][Full Text] [Related]
20. Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver.
Liu L; Zern MA; Lizarzaburu ME; Nantz MH; Wu J
Gene Ther; 2003 Jan; 10(2):180-7. PubMed ID: 12571647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
